BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.8 CNY | -1.90% |
|
-0.79% | -26.54% |
| 05-06 | Biocytogen Enters into Evaluation and Potential Licensing Agreement with Biocopy for TCR-mimic Antibodies | CI |
| 04-26 | Biocytogen Pharmaceuticals' Loss Narrows in 2023 | MT |
Evolution of the average Target Price on Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
f4b581f6dd251cda5f9058a6f23a.e0zDYENDFj7MS_vnWZa5mktWimPhciqPzUZQYZQ0Uh0.Hjq3AxoMJ0iOMY2oNOLOyxMl-yrQSnjAhjA3O6drNkkxC7YoChkkU6ImiA~f5c32474dc2801305febf0d5f35c3e33
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
8.165
CNY
Average target price
14.21
CNY
Spread / Average Target
+74.09%
High Price Target
15.02
CNY
Spread / Highest target
+83.91%
Low Price Target
13.41
CNY
Spread / Lowest Target
+64.27%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 2315 Stock
- Consensus Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
